Post by
JDavenport on Mar 17, 2022 10:43pm
xB3-004
Bioasis got that preclinical MS study done. That means that in addition to the several agreements signed, Bioasis got one of its own programs, xB3-004, underway. Progranulin soon. (Timing is about right.)
But what happens then with those two? BDs? Or just one to cover them both?
What about xB3-001? My guess is that somebody is working on that, probably has been for a while. Go read DrDR's quotes about these things. She's just aching to spill the beans. But she can't. Partners can be twits about these things, as I have posted for ten years.
But, xB3 is the key. Potential partners can't get through the doors without the key.
Can't wait.
jd
Comment by
Finallytherock on Mar 17, 2022 10:46pm
Any drugs in the clinic after 10+ years?
Comment by
Finallytherock on Mar 17, 2022 10:57pm
The company stopped paying you because they found no value in what you were saying. Finally, the company made a sensible decision
Comment by
JDavenport on Mar 18, 2022 12:54am
Here are my responses to MT's MT post. Yep. Nope. Me neither. History is in the past. Best understand that. Irrelevant Incomprehensible. Not my responsibility. Agreed. Agreed. Not really. Just opinions, which are like, you know, everyone has one. I had free meals, too. Would you turn 'em down? jd
Comment by
craighenry on Dec 28, 2022 5:37pm
Good "guess" nut job!! Again, you are sooooo special for being able to "read between the lines"!! I bet you were "just waiting " for this deal!!!!!! LoloLoL